昊帆生物：涉股权转让合同纠纷，公司217万元募资账户被冻结

Core Viewpoint - Haofan Bio (301393) announced that some of its fundraising special accounts and cash management accounts have been judicially frozen due to asset preservation measures related to a dispute over a share transfer contract with Yujun Bio [1] Group 1: Financial Impact - The actual frozen amount in the fundraising special account at Bank of China is 2.17 million yuan [1] - The frozen 2.17 million yuan accounts for 0.13% of the company's net fundraising amount [1] - The frozen funds primarily consist of contract payments that have not yet matured [1]